Minerva Surgical, Inc. (UTRS) Tops Q2 EPS by 14c

Minerva Surgical, Inc. (NASDAQ: UTRS) reported Q2 EPS of ($0.20), $0.14 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.47 million.

For earnings history and earnings-related data on Minerva Surgical, Inc. (UTRS) click here.

You May Also Be Interested In

• William Blair Downgrades On Holding AG (ONON) to Market Perform
• First Solar raised at Baird as Section 232 clears path for bookings
• Zura Bio (ZURA) Misses Q2 EPS by 2c